bluebird bio, Inc. (NASDAQ:BLUE) Receives $44.60 Average Target Price from Brokerages
bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) has received an average recommendation of “Hold” from the eight research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price […]
bluebird bio, Inc. (NASDAQ:BLUE – Get Free Report) has received an average recommendation of “Hold” from the eight research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year price […]
